JACKMAN STEPHAN (Chief Executive Officer) purchased 435.3% of their position (37K shares) of ALZAMEND NEURO, INC. on the open market
Open‑market purchase worth $20.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/2/2023ACC: 0001214659-23-006373
DirectorOfficer· Chief Executive Officer
Since Jun 2021
+37K
Net shares
Net buyer
$20.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
37K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+37K
Price / share
$0.54
Trade value
$20K
% of position
435.3%
4/28/2023
8.50K→45.50K
Total
Net shares
+37K
Net value
$20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/28/2023 | P · Purchase | +37K | $0.54 | $20K | 435.3% | 8.50K | 45.50K |
| Total | +37K | $20K | ||||||
Derivative Transactions0
No derivative transactions reported